middle.news
BlinkLab Raises A$17.5M, Secures US Patent, Advances FDA Autism Study and ADHD Research
9:08am on Monday 27th of July, 2026 AEST
•
Healthcare
Read Story
BlinkLab Raises A$17.5M, Secures US Patent, Advances FDA Autism Study and ADHD Research
9:08am on Monday 27th of July, 2026 AEST
Key Points
A$17.5 million placement completed to fund regulatory and commercial programs
Foundational US patent granted for remote neurobehavioural testing technology
FDA 510(k) pivotal autism study recruitment ongoing with completion expected by end 2026
European ADHD study recruitment complete; results imminent
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Blinklab (ASX:BB1)
OPEN ARTICLE